700 patients110,866 observations180 daysLIVE
← Patients

Patient P-02229

Synthetic patientMETA-24 · Day 118 · 55–64 · M · baseline S20Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
61%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 started — Baseline state S20

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • GI instability+25
  • Inflammatory activity+19
  • Toxicity+13
  • Nutritional resilience-12

What helped?

No interventions yet.

    LIFE OS recommendation
    GI Support Protocol GI-04
    49%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 72% showed improvement
    • median effect visible after 8 days
    View similar patientsSimulateAdd to intervention cohortAll evidence

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    44 min
    improving · +2.9 vs previous 14 d
    Sleep duration
    Wearable
    5.5 h
    stable · +0.2 vs previous 14 d
    Energy level
    Daily log
    3.7/10
    stable · +0.1 vs previous 14 d
    Steps
    Wearable
    4,834
    improving · +244 vs previous 14 d
    GI burden
    Companion
    42.1/100
    stable · +1.0 vs previous 14 d
    Adherence
    Companion
    92.6 %
    stable · +1.8 vs previous 14 d
    Sleep quality
    Wearable
    24.6/100
    improving · +3.4 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    138 mg/dL
    stable · -2.7 vs previous 14 d
    This trajectory is decaying — what would help, what would not
    Steering view →

    Heading towards failing · 50 from the failing basin, 37 from restoration.

    Would help
    • GI-04 GI Support Protocol
      72% improved among 25 similar · onset 8 d · confidence 51%
    • DT-01 Dosing / Timing Recommendation
      75% improved among 16 similar · onset 5 d · confidence 66%
    • HY-01 Hydration Protocol
      82% improved among 11 similar · onset 4 d · confidence 66%
    • More protein
      GI -3.7 next day on high-intake days · n 18
    Would not help
    • Keep simple carbs low
      GI +3.1 next day on high-intake days · n 17
    • Keep fat low
      GI +2.8 next day on high-intake days · n 22
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -3.7supporter · 95%
    • Simple carbohydrates
      +3.1detractor · 95%
    • Dietary fat load
      +2.8detractor · 95%
    • Histamine load
      +1.5no signal · 52%
    • Ultra-processed food
      +1.4no signal · 48%
    • Alcohol
      -0.7no signal · 19%
    • Insoluble fibre
      -0.6no signal · 16%
    • Caffeine
      0no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Butyrate / short-chain fatty acid production ↓60
      • MicrobiomeButyrate capacity 40/100
      • MicrobiomeF. prausnitzii depleted
    • Autonomic recovery ↓20
      • WearableShort sleep window
    • Inflammatory signalling ↑15
      • WearableHRV 34 ms, trending down
    • Mucosal barrier integrity ↓10
      • WearableSleep 5.5 h, below personal baseline
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 2.1 · butyrate capacity 40/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisNormal
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    39 ms
    Sleep
    6.4 h
    Steps
    4,836
    Resting HR
    69 bpm
    Daily log: GI score 42, nutritional resilience 53, adherence 93.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
    • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Track each bowel movement today: time, stool form, urgency, overnight waking
    • A 15-minute walk after lunch
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • Electrolyte solution, one sachet after any loose stool
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0259941%S14HY-01improved54
    P-0232140%S17GI-04improved54
    P-0203739%S04GI-04improved53
    P-0253839%S02GI-04improved59
    P-0227438%S15DT-01improved50
    P-0245938%S05HY-01improved52
    P-0233937%S03DT-01improved50
    P-0239537%S12DT-01improved57
    P-0203336%S06GI-04improved51
    P-0222336%S20HY-01improved49
    P-0223536%S14DT-01improved50
    P-0215035%S11HY-01improved45